Non-Dose-Dependent Changes in Liver Enzyme Levels of Children With Epilepsy on Treatment With Sodium Valproate

BACKGROUND: Sodium valproate (VPA) is considered as the drug of choice for the treatment of generalized epilepsy in children. Sodium Valproate may be hepatotoxic. AIM: To assess the level of derangement of liver enzymes in children with epilepsy on treatment with sodium valproate. METHODS: A cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Adedapo, Aduragbenro Deborah A., Demaki, Winifred Eseoghene, Lagunju, IkeOluwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180311/
https://www.ncbi.nlm.nih.gov/pubmed/32362796
http://dx.doi.org/10.1177/1559325820918445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180311/
https://www.ncbi.nlm.nih.gov/pubmed/32362796
http://dx.doi.org/10.1177/1559325820918445

Ejemplares similares